#SFHS2612866VPatient cost-sharing set for Sandoz low-dose aspirin medicines
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
France sets the patient cost-sharing rate at 35% for four Sandoz acetylsalicylic acid medicines in 75 mg and 100 mg gastro-resistant tablet packs. This mainly affects patients, pharmacies, prescribers, and reimbursement teams handling these products. The notice is narrow and factual: it fixes the insured person’s share for the listed medicines, rather than changing wider health policy.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Sets a 35% patient cost-sharing rate for listed Sandoz acetylsalicylic acid medicines.
- Covers 75 mg and 100 mg gastro-resistant tablet presentations in packs of 30 and 90.
- Gives pharmacies and reimbursement teams the applicable rate for these specific CIP-coded products.
Obligations
What this law requires
Apply a 35% insured-person participation rate to ACIDE ACETYLSALICYLIQUE SANDOZ 100 mg gastro-resistant tablets, blister pack B/30, CIP 34009 303 221 9 2.
Apply a 35% insured-person participation rate to ACIDE ACETYLSALICYLIQUE SANDOZ 100 mg gastro-resistant tablets, blister pack B/90, CIP 34009 303 222 0 8.
Apply a 35% insured-person participation rate to ACIDE ACETYLSALICYLIQUE SANDOZ 75 mg gastro-resistant tablets, blister pack B/30, CIP 34009 303 221 7 8.
Apply a 35% insured-person participation rate to ACIDE ACETYLSALICYLIQUE SANDOZ 75 mg gastro-resistant tablets, blister pack B/90, CIP 34009 303 221 8 5.